Breast-conserving therapy for Stage I-II synchronous bilateral breast carcinoma

Abstract

Patients with early-stage SBBC can be safely treated with carefully planned, bilateral BCT, with outcome that appears to be comparable to that of patients with early-stage unilateral breast carcinoma.